HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-DEC-10 3PZE TITLE JNK1 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 8; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 7-364; COMPND 5 SYNONYM: MAP KINASE 8, MAPK 8, JNK-46, STRESS-ACTIVATED PROTEIN COMPND 6 KINASE 1, STRESS-ACTIVATED PROTEIN KINASE JNK1, C-JUN N-TERMINAL COMPND 7 KINASE 1; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK8, JNK1, PRKM8, SAPK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE JNK1, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE REVDAT 5 21-FEB-24 3PZE 1 REMARK REVDAT 4 07-MAR-18 3PZE 1 REMARK REVDAT 3 27-JUN-12 3PZE 1 JRNL REVDAT 2 16-MAY-12 3PZE 1 JRNL REVDAT 1 14-DEC-11 3PZE 0 JRNL AUTH V.OZA,S.ASHWELL,L.ALMEIDA,P.BRASSIL,J.BREED,C.DENG,T.GERO, JRNL AUTH 2 M.GRONDINE,C.HORN,S.IOANNIDIS,D.LIU,P.LYNE,N.NEWCOMBE, JRNL AUTH 3 M.PASS,J.READ,S.READY,S.ROWSELL,M.SU,D.TOADER,M.VASBINDER, JRNL AUTH 4 D.YU,Y.YU,Y.XUE,S.ZABLUDOFF,J.JANETKA JRNL TITL DISCOVERY OF CHECKPOINT KINASE INHIBITOR JRNL TITL 2 (S)-5-(3-FLUOROPHENYL)-N-(PIPERIDIN-3-YL) JRNL TITL 3 -3-UREIDOTHIOPHENE-2-CARBOXAMIDE (AZD7762) BY JRNL TITL 4 STRUCTURE-BASED DESIGN AND OPTIMIZATION OF JRNL TITL 5 THIOPHENECARBOXAMIDE UREAS. JRNL REF J.MED.CHEM. V. 55 5130 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22551018 JRNL DOI 10.1021/JM300025R REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 25353 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1041 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.49 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2738 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2274 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2635 REMARK 3 BIN R VALUE (WORKING SET) : 0.2271 REMARK 3 BIN FREE R VALUE : 0.2381 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.76 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 103 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2816 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 177 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.48450 REMARK 3 B22 (A**2) : 3.20420 REMARK 3 B33 (A**2) : 6.28030 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.232 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2914 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 3940 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 1029 ; 2.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 77 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 406 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 2914 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 368 ; 5.000 ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3526 ; 4.000 ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.12 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.20 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.15 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3PZE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1000063000. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I711 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0159 REMARK 200 MONOCHROMATOR : SI (111) CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25419 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 31.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG2000 MME, 100 MM HEPES, 10 MM REMARK 280 DTT, PH 7, EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.79300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.36550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.68900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.36550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.79300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.68900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 173 REMARK 465 ARG A 174 REMARK 465 THR A 175 REMARK 465 ALA A 176 REMARK 465 GLY A 177 REMARK 465 THR A 178 REMARK 465 PRO A 184 REMARK 465 TYR A 185 REMARK 465 VAL A 186 REMARK 465 LEU A 363 REMARK 465 GLU A 364 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 59 65.20 33.25 REMARK 500 GLN A 102 -55.87 -132.49 REMARK 500 ARG A 150 -21.03 74.31 REMARK 500 ALA A 282 28.39 -152.02 REMARK 500 PRO A 338 82.70 -62.92 REMARK 500 ASP A 339 -153.34 48.16 REMARK 500 LYS A 340 17.98 -59.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CFK A 1 DBREF 3PZE A 7 364 UNP P45983 MK08_HUMAN 7 364 SEQRES 1 A 358 ASP ASN ASN PHE TYR SER VAL GLU ILE GLY ASP SER THR SEQRES 2 A 358 PHE THR VAL LEU LYS ARG TYR GLN ASN LEU LYS PRO ILE SEQRES 3 A 358 GLY SER GLY ALA GLN GLY ILE VAL CYS ALA ALA TYR ASP SEQRES 4 A 358 ALA ILE LEU GLU ARG ASN VAL ALA ILE LYS LYS LEU SER SEQRES 5 A 358 ARG PRO PHE GLN ASN GLN THR HIS ALA LYS ARG ALA TYR SEQRES 6 A 358 ARG GLU LEU VAL LEU MET LYS CYS VAL ASN HIS LYS ASN SEQRES 7 A 358 ILE ILE GLY LEU LEU ASN VAL PHE THR PRO GLN LYS SER SEQRES 8 A 358 LEU GLU GLU PHE GLN ASP VAL TYR ILE VAL MET GLU LEU SEQRES 9 A 358 MET ASP ALA ASN LEU CYS GLN VAL ILE GLN MET GLU LEU SEQRES 10 A 358 ASP HIS GLU ARG MET SER TYR LEU LEU TYR GLN MET LEU SEQRES 11 A 358 CYS GLY ILE LYS HIS LEU HIS SER ALA GLY ILE ILE HIS SEQRES 12 A 358 ARG ASP LEU LYS PRO SER ASN ILE VAL VAL LYS SER ASP SEQRES 13 A 358 CYS THR LEU LYS ILE LEU ASP PHE GLY LEU ALA ARG THR SEQRES 14 A 358 ALA GLY THR SER PHE MET MET THR PRO TYR VAL VAL THR SEQRES 15 A 358 ARG TYR TYR ARG ALA PRO GLU VAL ILE LEU GLY MET GLY SEQRES 16 A 358 TYR LYS GLU ASN VAL ASP LEU TRP SER VAL GLY CYS ILE SEQRES 17 A 358 MET GLY GLU MET VAL CYS HIS LYS ILE LEU PHE PRO GLY SEQRES 18 A 358 ARG ASP TYR ILE ASP GLN TRP ASN LYS VAL ILE GLU GLN SEQRES 19 A 358 LEU GLY THR PRO CYS PRO GLU PHE MET LYS LYS LEU GLN SEQRES 20 A 358 PRO THR VAL ARG THR TYR VAL GLU ASN ARG PRO LYS TYR SEQRES 21 A 358 ALA GLY TYR SER PHE GLU LYS LEU PHE PRO ASP VAL LEU SEQRES 22 A 358 PHE PRO ALA ASP SER GLU HIS ASN LYS LEU LYS ALA SER SEQRES 23 A 358 GLN ALA ARG ASP LEU LEU SER LYS MET LEU VAL ILE ASP SEQRES 24 A 358 ALA SER LYS ARG ILE SER VAL ASP GLU ALA LEU GLN HIS SEQRES 25 A 358 PRO TYR ILE ASN VAL TRP TYR ASP PRO SER GLU ALA GLU SEQRES 26 A 358 ALA PRO PRO PRO LYS ILE PRO ASP LYS GLN LEU ASP GLU SEQRES 27 A 358 ARG GLU HIS THR ILE GLU GLU TRP LYS GLU LEU ILE TYR SEQRES 28 A 358 LYS GLU VAL MET ASP LEU GLU HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HET SO4 A 405 5 HET CFK A 1 18 HETNAM SO4 SULFATE ION HETNAM CFK 3-(CARBAMOYLAMINO)-5-PHENYLTHIOPHENE-2-CARBOXAMIDE FORMUL 2 SO4 4(O4 S 2-) FORMUL 6 CFK C12 H11 N3 O2 S FORMUL 7 HOH *177(H2 O) HELIX 1 1 PRO A 60 GLN A 62 5 3 HELIX 2 2 ASN A 63 VAL A 80 1 18 HELIX 3 3 LEU A 115 GLN A 120 1 6 HELIX 4 4 ASP A 124 ALA A 145 1 22 HELIX 5 5 LYS A 153 SER A 155 5 3 HELIX 6 6 THR A 188 ARG A 192 5 5 HELIX 7 7 ALA A 193 LEU A 198 1 6 HELIX 8 8 ASN A 205 HIS A 221 1 17 HELIX 9 9 ASP A 229 GLY A 242 1 14 HELIX 10 10 CYS A 245 LYS A 250 1 6 HELIX 11 11 GLN A 253 ASN A 262 1 10 HELIX 12 12 SER A 270 PHE A 275 1 6 HELIX 13 13 PRO A 276 PHE A 280 5 5 HELIX 14 14 SER A 284 LEU A 302 1 19 HELIX 15 15 ASP A 305 ARG A 309 5 5 HELIX 16 16 SER A 311 GLN A 317 1 7 HELIX 17 17 ILE A 321 TYR A 325 5 5 HELIX 18 18 ASP A 326 GLU A 331 1 6 HELIX 19 19 PRO A 338 ASP A 343 5 6 HELIX 20 20 THR A 348 ASP A 362 1 15 SHEET 1 A 2 PHE A 10 ILE A 15 0 SHEET 2 A 2 SER A 18 LEU A 23 -1 O SER A 18 N ILE A 15 SHEET 1 B 5 TYR A 26 SER A 34 0 SHEET 2 B 5 ILE A 39 ASP A 45 -1 O TYR A 44 N GLN A 27 SHEET 3 B 5 ARG A 50 SER A 58 -1 O VAL A 52 N ALA A 43 SHEET 4 B 5 ASP A 103 GLU A 109 -1 O VAL A 104 N LEU A 57 SHEET 5 B 5 LEU A 88 PHE A 92 -1 N PHE A 92 O TYR A 105 SHEET 1 C 3 ALA A 113 ASN A 114 0 SHEET 2 C 3 ILE A 157 VAL A 159 -1 O VAL A 159 N ALA A 113 SHEET 3 C 3 LEU A 165 ILE A 167 -1 O LYS A 166 N VAL A 158 SITE 1 AC1 5 GLY A 35 ALA A 36 ARG A 69 LYS A 153 SITE 2 AC1 5 HOH A 423 SITE 1 AC2 4 ARG A 25 LEU A 48 LYS A 288 HOH A 390 SITE 1 AC3 8 PRO A 244 CYS A 245 VAL A 303 ILE A 304 SITE 2 AC3 8 ASP A 305 HOH A 368 HOH A 393 HOH A 429 SITE 1 AC4 4 THR A 188 ARG A 189 ARG A 192 TYR A 230 SITE 1 AC5 10 ILE A 32 SER A 34 VAL A 40 ALA A 53 SITE 2 AC5 10 GLU A 109 LEU A 110 MET A 111 ASP A 112 SITE 3 AC5 10 ALA A 113 LEU A 168 CRYST1 49.586 71.378 106.731 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020167 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014010 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009369 0.00000